Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inactivated Influenza Vaccine”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02598089
What this trial is testing

Seasonal Trivalent Inactivated Split Virion Influenza Vaccine Clinical Trial (IVACFLU-S)

Who this might be right for
Influenza, Human
Institute of Vaccines and Medical Biologicals, Vietnam 60
Large-scale testing (Phase 3)Study completedNCT00972816
What this trial is testing

Safety and Immunogenicity of A/H1N1-SOIV (Swine Flu) Vaccine With and Without Adjuvant in Children (3 to < 9 Years)

Who this might be right for
Influenza
Novartis Vaccines 1,357
Early research (Phase 1)Study completedNCT02269007
What this trial is testing

A Phase I Clinical Trial for Inactivated Quadrivalent Influenza Vaccine (Split Virion) in Healthy Adults in China

Who this might be right for
Influenza
Jiangsu Province Centers for Disease Control and Prevention 110
Testing effectiveness (Phase 2)Study completedNCT01181323
What this trial is testing

Post-Partum Immunization With Live Attenuated Influenza Vaccine (LAIV) or Trivalent Influenza Vaccine (TIV) in Post-Partum Breast Feeding Women

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 240
Large-scale testing (Phase 3)Study completedNCT02914275
What this trial is testing

Evaluate the Immunogenicity and Safety of Seqirus Quadrivalent Influenza Vaccine (QIV) in a Pediatric Population 6 Months Through 59 Months of Age.

Who this might be right for
Influenza, Human
Seqirus 2,250
Post-approval studies (Phase 4)Study completedNCT01355172
What this trial is testing

Immunogenicity and Safety of AdimFlu-S, Formulation 2010-2011, in Infants Aged Between 6-12months Old

Who this might be right for
Influenza
Adimmune Corporation 59
Testing effectiveness (Phase 2)Study completedNCT01140009
What this trial is testing

Safety and Protectiveness of the Seasonal Influenza Vaccine for 2010-2011

Who this might be right for
Influenza
University of British Columbia 324
Testing effectiveness (Phase 2)Study completedNCT01344057
What this trial is testing

Study to Evaluate Safety and Immunogenicity of Sub-unit Adjuvanted Influenza Vaccine Administered to Elderly Subjects, Formulation 2011-2012

Who this might be right for
Seasonal Influenza
Novartis Vaccines 63
Post-approval studies (Phase 4)Study completedNCT03022435
What this trial is testing

T-cell And General Immune Response to Seasonal Influenza Vaccine (SLVP018) Year 4, 2012

Who this might be right for
Influenza
Stanford University 22
Not applicableStudy completedNCT05078060
What this trial is testing

Safety Surveillance of VaxigripTetra® and Efluelda® Influenza Vaccines in Europe During the Influenza Season 2021/22

Who this might be right for
Influenza (Healthy Volunteers)
Sanofi Pasteur, a Sanofi Company 1,804
Testing effectiveness (Phase 2)Study completedNCT00845429
What this trial is testing

Immunogenicity of a Split, Cell-Based, Inactivated, Trivalent Influenza Vaccine in Healthy Adult Subjects

Who this might be right for
InfluenzaOrthomyxovirusesMyxovirus Infection
Sanofi 729
Post-approval studies (Phase 4)WithdrawnNCT01097941
What this trial is testing

Effect of Age and Prior Immunity on Response to H1N1 Vaccines in Children

Who this might be right for
2009 H1N1 Influenza
University of Rochester
Post-approval studies (Phase 4)Study completedNCT03022422
What this trial is testing

T-cell And General Immune Response to Seasonal Influenza Vaccine (SLVP018) Year 3, 2011

Who this might be right for
Influenza
Stanford University 63
Post-approval studies (Phase 4)Study completedNCT01008137
What this trial is testing

Sinovac, H1N1 Vaccine + Trivalent Inactivated Influenza Vaccine, Adults

Who this might be right for
Influenza
Sinovac Biotech Co., Ltd 150
Early research (Phase 1)Study completedNCT01928472
What this trial is testing

Dose-finding Study of Four Dosage Levels of an H7N9 Influenza Vaccine in Adults Between Ages of 18 Years and 65 Years

Who this might be right for
H7N9 Influenza
Novartis Vaccines 402
Testing effectiveness (Phase 2)Study completedNCT00680069
What this trial is testing

H5N1 (Clade 2) Vaccination of Adults and Elderly

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 517
Testing effectiveness (Phase 2)Study completedNCT00617331
What this trial is testing

H9 Priming Study in Healthy Adults

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 121
Post-approval studies (Phase 4)Study completedNCT02133781
What this trial is testing

B-cell Immunity to Influenza (SLVP017)- Year 1, 2009

Who this might be right for
Influenza
Stanford University 51
Large-scale testing (Phase 3)Study completedNCT01422512
What this trial is testing

Safety and Immunogenicity of One Dose of a Surface, Antigen, Inactivated, Influenza Vaccine Produced in Mammalian Cell Culture Administered to Adult and Elderly Subjects

Who this might be right for
Influenza
Novartis Vaccines 126
Testing effectiveness (Phase 2)Study completedNCT01357265
What this trial is testing

Safety and Immunogenicity of One Dose of an Inactivated Trivalent Sub-unit Influenza Vaccine Administered to Non-elderly Adult and Elderly Subjects

Who this might be right for
Influenza
Novartis Vaccines 125
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation